Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Viswanathan

Showing results (231-240 of 244) with videos related to

Pageof 25
Sort By:
Nature Metabolism|February 6, 2025
Oncogenic TFE3 fusions drive OXPHOS and confer metabolic vulnerabilities in translocation renal cell carcinomaJiao Li, Kaimeng Huang, Meha Thakur, et al.
Nature Genetics|June 2, 2009
Lin28 promotes transformation and is associated with advanced human malignanciesSrinivas R Viswanathan, John T Powers, William Einhorn, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 29, 2025
Suspended Tissue Open Microfluidic Patterning (STOMP)Amanda J Haack, Lauren G Brown, Alex J Goldstein, et al.
Nature Genetics|June 30, 2018
Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancerSrinivas R Viswanathan, Marina F Nogueira, Colin G Buss, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Suspended Tissue Open Microfluidic Patterning (STOMP)Amanda J Haack, Lauren G Brown, Alex J Goldstein, et al.
Cell Reports|February 23, 2022
A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancerStephen Tang, Vidyalakshmi Sethunath, Nebiyou Y Metaferia, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Detection and monitoring of translocation renal cell carcinoma via plasma cell-free epigenomic profilingSimon Garinet, Karl Semaan, Jiao Li, et al.
Cell|June 19, 2018
Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome SequencingSrinivas R Viswanathan, Gavin Ha, Andreas M Hoff, et al.
The Journal of Clinical Investigation|February 2, 2026
Cell-free DNA epigenomic profiling enables noninvasive detection and monitoring of translocation renal cell carcinomaSimon Garinet, Karl Semaan, Jiao Li, et al.
Cell Reports|January 5, 2022
Integrative clinical and molecular characterization of translocation renal cell carcinomaZiad Bakouny, Ananthan Sadagopan, Praful Ravi, et al.
Pageof 25

Showing results (231-240 of 244) with videos related to

Sort By:
Pageof 25
Nature Metabolism|February 6, 2025
Oncogenic TFE3 fusions drive OXPHOS and confer metabolic vulnerabilities in translocation renal cell carcinomaJiao Li, Kaimeng Huang, Meha Thakur, et al.
Nature Genetics|June 2, 2009
Lin28 promotes transformation and is associated with advanced human malignanciesSrinivas R Viswanathan, John T Powers, William Einhorn, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 29, 2025
Suspended Tissue Open Microfluidic Patterning (STOMP)Amanda J Haack, Lauren G Brown, Alex J Goldstein, et al.
Nature Genetics|June 30, 2018
Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancerSrinivas R Viswanathan, Marina F Nogueira, Colin G Buss, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Suspended Tissue Open Microfluidic Patterning (STOMP)Amanda J Haack, Lauren G Brown, Alex J Goldstein, et al.
Cell Reports|February 23, 2022
A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancerStephen Tang, Vidyalakshmi Sethunath, Nebiyou Y Metaferia, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Detection and monitoring of translocation renal cell carcinoma via plasma cell-free epigenomic profilingSimon Garinet, Karl Semaan, Jiao Li, et al.
Cell|June 19, 2018
Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome SequencingSrinivas R Viswanathan, Gavin Ha, Andreas M Hoff, et al.
The Journal of Clinical Investigation|February 2, 2026
Cell-free DNA epigenomic profiling enables noninvasive detection and monitoring of translocation renal cell carcinomaSimon Garinet, Karl Semaan, Jiao Li, et al.
Cell Reports|January 5, 2022
Integrative clinical and molecular characterization of translocation renal cell carcinomaZiad Bakouny, Ananthan Sadagopan, Praful Ravi, et al.
Pageof 25